Visit WTR Logo
Click here to see our best subscription offers
Dosage patents come under scrutiny at UK Supreme Court

Justices today considering a much-anticipated case whose outcome could make it harder for pharma companies to obtain such protection in the future

Dosage patents come under scrutiny at UK Supreme Court
19 Nov 2018

Numbers confirm Baidu as China’s top AI patent player

The search firm is carrying the country's banner both domestically and overseas. Report also shows which foreign companies file the most in rapidly-expanding tech area

18 Nov 2018

Pfizer's $650 million setback; how Red Hat's patents will boost IBM; Qualcomm's $4 billion loss; Dolby Labs' IP secrets; and much more

Your essential Sunday reading: a summary of all the stories posted on the IAM platform in the past week - as well as links to each one

Featured

17 Nov
2018

Open source practices to support in-house innovation

How to ensure that the use of open source packages does not run contrary to corporate IP policies Read more

16 Nov
2018

Apple, Comcast and Qualcomm lead stampede to the PTAB before key rule change

Shift to Phillips claim construction standard brings Board in line with district courts and could make it harder to invalidate patents in a venue that many rights owners have come to dread  Read more

16 Nov
2018

How Dolby uses IP to turn world class innovation into bottom line returns

The inside track on a 50-year exercise in managing a multi-dimensional value creation strategy that keeps on delivering successful results Read more

Most reads

1

Licensing SEPs for the Internet of Things

2

Je ne regrette rien – Battistelli, the final interview

3

Nokia announces it is joining Avanci

4

Four patent lessons the tech sector can teach life sciences companies

5

Oppo’s latest patent acquisition underlines focus on Europe  

News

View all
15 Nov 2018

Congress needs role in key patent reform debates, says senior GOP legislator

Tipped to be the ranking Republican on the House Judiciary Committee, Doug Collins looks set to emerge as one of most powerful IP policy voices on Capitol Hill Read more

15 Nov 2018

The big life sciences IP developments from October 2018

Cannabis patent war looming, “New NAFTA” set to benefit biopharma innovators, a blow for medical device inventors at the CJEU, and much more in this round-up of October’s big life sciences IP news Read more

15 Nov 2018

Jury still out on foreign NPEs in China

Firms like iPEL are creating a buzz in the country's patent market, but as of yet there are few indications that Beijing will roll out the welcome mat Read more

14 Nov 2018

Modernise or die – why corporates need to push their patents

Legal requirements and market realities mean that boards and directors who fail to prioritise their intellectual property risk their companies’ future. But there is already a model from which they can draw crucial lessons Read more

Analysis

View all
16 Nov 2018

IP Bridge earns first US litigation win

Jury verdict comes three years after the Japanese sovereign patent fund led by CEO Shigeharu Yoshii (pictured, centre) made Chinese mobile maker TCL its first US litigation target. Read more

13 Nov 2018

Red Hat’s patents will help IBM build cloud presence, exclusive analysis reveals

The open source business’s portfolio is not big, but should bolster Big Blue’s attempts to bridge the gap with Amazon, Google and Microsoft in a space that is rapidly growing in importance. Read more

13 Nov 2018

IP trade war puts spotlight on university collaborations  

Johns Hopkins and the University of Wisconsin both had research collaborations come under the microscope for IP reasons last week. Read more

12 Nov 2018

New USPTO deputy director has her own track record criticising the “troll” narrative

Former deputy general counsel of A10 Networks appointed to serve as Director Iancu’s number two and seems to share her boss’s opinion on one of the patent reform movement’s hobby horses Read more

Events

View all
13 Nov
2018
Latest

Patent Law & Policy 2018

In the past three years IAM’s Patent Law & Policy has established itself as the leading Washington DC event for anyone interested in how the legal and political climates shape the patent market. As well as considering what has happened in the field, this event analyses recent developments and the impact they could have on future proceedings.

2-4 Dec
2018
Latest

IPBC Asia 2018

The Asia-Pacific region is cementing its position as the focus point for the international IP market as its rapid development drives deal making, IP investment and litigation trends. Against this background, IAM is pleased to be returning to Shanghai for the sixth IPBC Asia, hosted at the Ritz-Carlton Pudong on December 2 to 4 2018.

16-18 June
2019
Latest

IPBC Global 2019

The leading gathering of global IP decision makers and thought-leaders returns to Boston! As the fourth industrial revolution gathers pace, IPBC Global’s 2019 programme explores the key IP issues this new era of change and innovation presents for corporate leaders, policy makers, investors, the legal profession and third-party service providers.

Insights

27 Sep 2018

A Brexit IP issue with serious political consequences

The UPC and EU trademarks will not inflame any Brexit passions among those outside the IP bubble, but geographical indications are a different matter altogether Read more

27 Sep 2018

IP market news highlights

Some of the major stories carried on the www.IAM-media.com platform in August and September Read more

1 Aug 2018

As the US trade war intensifies, pro-plaintiff China may not be what it seems

A new US NPE with big-money backing has identified China as the place in which to build a major licensing programme. However, recent geopolitical and courtroom developments might give its owners some pause for thought. Read more

1 Aug 2018

Seen and heard

A round-up of IP-related quotes, observations and opinions from the recent past … Read more

Analysis

Latest analysis reports from IAM.

Thought leadership

IAM offers an extensive range of special reports.

Why subscribe?

Our unique and timely intelligence service informs commercial trademark decision making in boardrooms globally by translating trademark law into business sense.

Subscribe now
We use cookies on www.iam-media.com. By using this site, you agree that we may store and access cookies on your device. For further information please read our cookie policy and our terms and conditions.